Have a feature idea you'd love to see implemented?
Let us know!
GOVX GeoVax Labs Inc
Price (delayed)
$2.7
Market cap
$25.48M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$9.31
Enterprise value
$16.88M
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On
Highlights
The debt has dropped by 100% since the previous quarter
The quick ratio has soared by 96% YoY
GeoVax Labs's net income has increased by 10% from the previous quarter but it has decreased by 2.4% YoY
The equity has declined by 7% year-on-year
Key stats
What are the main financial stats of GOVX
Market
Valuations
Earnings
Shares outstanding
9.44M
Market cap
$25.48M
Enterprise value
$16.88M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.02
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$24.3M
EBITDA
-$24.2M
Free cash flow
-$27.24M
Per share
Balance sheet
Liquidity
EPS
-$9.31
Free cash flow per share
-$4.25
Book value per share
$0.9
Revenue per share
$0
TBVPS
$1.73
Total assets
$11.11M
Total liabilities
$2.61M
Debt
$0
Equity
$8.5M
Working capital
$8.26M
Debt to equity
0
Current ratio
4.17
Quick ratio
3.5
Net debt/EBITDA
0.35
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-349.3%
Return on equity
-809.9%
Return on invested capital
N/A
Return on capital employed
-285.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GOVX stock price
How has the GeoVax Labs stock price performed over time
Intraday
3.45%
1 week
3.45%
1 month
20.54%
1 year
-65.38%
YTD
-50.09%
QTD
12.03%
Financial performance
How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$27.58M
Net income
-$24.32M
Gross margin
N/A
Net margin
N/A
The operating income has contracted by 13% YoY
GeoVax Labs's net income has increased by 10% from the previous quarter but it has decreased by 2.4% YoY
Growth
What is GeoVax Labs's growth rate over time
Valuation
What is GeoVax Labs stock price valuation
P/E
N/A
P/B
3.02
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 32% year-on-year and by 29% since the previous quarter
The P/B is 53% less than the 5-year quarterly average of 6.4
The equity has declined by 7% year-on-year
Efficiency
How efficient is GeoVax Labs business performance
The ROA has declined by 7% since the previous quarter
The return on equity rose by 5% since the previous quarter
Dividends
What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GOVX.
Financial health
How did GeoVax Labs financials performed over time
GOVX's total assets has soared by 171% from the previous quarter but it is down by 31% YoY
The current ratio has soared by 100% year-on-year
The debt is 100% smaller than the equity
The debt has dropped by 100% since the previous quarter
The debt to equity has soared by 100% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.